Filing Details
- Accession Number:
- 0000904454-14-000731
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-12 15:06:17
- Reporting Period:
- 2014-11-12
- Filing Date:
- 2014-11-12
- Accepted Time:
- 2014-11-12 15:06:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
200406 | Johnson & Johnson | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | No | No | Yes | No | |
924020 | Johnson & Johnson Development Corp Et Al | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-12 | 3,037,005 | $0.00 | 3,037,005 | No | 4 | C | Indirect | Johnson & Johnson Development Corporation |
Common Stock | Acquisiton | 2014-11-12 | 40,000 | $18.00 | 3,077,005 | No | 4 | P | Indirect | By Johnson & Johnson Development Corporation |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | Johnson & Johnson Development Corporation |
No | 4 | P | Indirect | By Johnson & Johnson Development Corporation |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-11-12 | 2,790,178 | $0.00 | 2,790,178 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2014-11-12 | 246,827 | $0.00 | 246,827 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person.
- Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional consideration. There was no expiration applicable to the Preferred Stock.